Hartford Financial Management Inc. - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 53 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Hartford Financial Management Inc. ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,996
+21.1%
16,0000.0%0.00%
Q4 2022$1,648
-17.6%
16,0000.0%0.00%
-100.0%
Q3 2022$2,000
-85.7%
16,0000.0%0.00%
-75.0%
Q2 2022$14,000
-30.0%
16,0000.0%0.00%
-20.0%
Q1 2022$20,000
-35.5%
16,0000.0%0.01%
-28.6%
Q4 2021$31,000
-29.5%
16,0000.0%0.01%
-36.4%
Q3 2021$44,000
-12.0%
16,0000.0%0.01%
-8.3%
Q2 2021$50,000
+47.1%
16,0000.0%0.01%
+50.0%
Q1 2021$34,000
+9.7%
16,0000.0%0.01%0.0%
Q4 2020$31,000
+181.8%
16,0000.0%0.01%
+166.7%
Q3 2020$11,000
+37.5%
16,0000.0%0.00%0.0%
Q2 2020$8,000
+14.3%
16,0000.0%0.00%0.0%
Q1 2020$7,000
-36.4%
16,0000.0%0.00%0.0%
Q4 2019$11,000
-35.3%
16,0000.0%0.00%
-50.0%
Q3 2019$17,000
+41.7%
16,0000.0%0.01%
+50.0%
Q2 2019$12,000
-33.3%
16,000
+14.3%
0.00%
-33.3%
Q1 2019$18,000
+1700.0%
14,000
+976.9%
0.01%
Q4 2017$1,000
-50.0%
1,3000.0%0.00%
-100.0%
Q3 2017$2,0000.0%1,3000.0%0.00%0.0%
Q2 2017$2,0000.0%1,3000.0%0.00%0.0%
Q1 2017$2,000
-60.0%
1,3000.0%0.00%
-66.7%
Q4 2016$5,0000.0%1,3000.0%0.00%0.0%
Q3 2016$5,000
+25.0%
1,300
+18.2%
0.00%
+50.0%
Q2 2016$4,0001,1000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders